Search results
Find the latest Affimed N.V. (AFMD) stock quote, history, news and other vital information to help you with your stock trading and investing.
Affimed (AFMD) is pioneering a transformative innate immunity therapeutic approach to eradicating solid and hematologic tumors to help patients fight cancer.
Affimed is a clinical-stage immuno-oncology company developing innate cell engagers for cancer treatment. See its stock price, financial results, clinical trials, news and analyst ratings.
Get the latest Affimed NV (AFMD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
AFMD - Affimed N.V. - Stock screener for investors and traders, financial visualizations.
Jun 20, 2024 · Affimed N.V. is a biotechnology company developing immunotherapies for cancer and autoimmune diseases. See its stock performance, analyst ratings, recent news and events on MarketWatch.
May 17, 2024 · Affimed N.V. is a biotechnology company that develops immunotherapies for cancer and infectious diseases. See its stock performance, earnings, analyst ratings, and latest news on Nasdaq.